Genmab (CPSE:GMAB) Valuation Check After Recent Share Price Weakness [Yahoo! Finance]
Genmab A/S - American Depositary Shares (GMAB)
Company Research
Source: Yahoo! Finance
Genmab (CPSE:GMAB) shares have been under pressure recently, with a return of about a 10% decline over the past month and roughly a 9% decline over the past 3 months, despite a 15% total return over the past year. See our latest analysis for Genmab. The recent 1 month share price return of a 9.8% decline and 3 month share price return of a 9.3% decline suggest momentum has cooled, even though the 1 year total shareholder return of 14.9% remains positive. If Genmab's recent swings have you reassessing your watchlist, it could be a good time to broaden your search with our 113 healthcare AI stocks on Simply Wall St. So with the share price under pressure, annual revenue of 3,720m DKK and net income of 963m DKK, is Genmab quietly offering value here or is the market already pricing in everything ahead? Most Popular Narrative: 15.3% Undervalued The most followed Genmab narrative pegs fair value at DKK2,182, compared with a last close of DKK1,848.5, putting a clear gap between
Show less
Read more
Impact Snapshot
Event Time:
GMAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GMAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GMAB alerts
High impacting Genmab A/S - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
GMAB
News
- Genmab A/S (GMAB) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $40.00 price target on the stock.MarketBeat
- Transactions in Connection with Share Buy-back Program [Yahoo! Finance]Yahoo! Finance
- Is Genmab (CPSE:GMAB) Pricing Look Attractive After Recent Share Price Weakness [Yahoo! Finance]Yahoo! Finance
- Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab [Yahoo! Finance]Yahoo! Finance
- Genmab to Participate in Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance